Adventure after rebirth

Su Yuan sorted out the data hard drive, took a stack of paper materials, and casually held them in his hands, and did not take any measures to keep them secret. Su Yuan did not have this common sense, and Leander did not mind. Strong bodyguards, robbery or something, that's delusional.Su Yuan has Su Yuan's work to do, Leander also has to be busy with the group's affairs, and they act separately.

Su Yuan was sitting in the car, and would receive calls from Professor Kelun from time to time, and would come to ask if Su Yuan had arrived every 10 minutes.Su Yuan was really impatient. If it wasn't for the fact that the professor was his tutor and why the professor was so anxious, he really wanted to cut off the phone.Now, he can only be patient and explain over and over again.

The car finally arrived at the entrance of the college. Su Yuan saw Professor Ke Lun waiting outside the door, and got out of the car quickly. Professor Ke Lun came over immediately, took Su Yuan's hand, and ran into the laboratory.

"Where's the thing?" As soon as he entered the laboratory, Professor Ke Lun hurriedly said that the data disk opportunity that Su Yuan took out was snatched by Professor Ke Lun.

Professor Ke Lun was looking at the data, and Su Yuan became redundant. Fortunately, as a student of Professor Ke Lun, Su Yuan was very familiar with this situation. He was doing it quietly, flipping through the latest subscriptions introduced by Ke Lun here. Tech Magazine.

"It's great, it's perfect." After a long time, after Professor Kelun over there finished reading it, he kept screaming in praise, raised his head, and finally looked at Su Yuan, very gratified , even with admiration, his students did it and defeated that terrible terminal illness. From now on, human beings no longer need to be afraid of that terminal illness.As a scholar who is devoted to pharmacology and wants to benefit all mankind, how can Professor Kelun not be excited.

Regardless of how Professor Ke Lun expressed his excitement to Su Yuan, Su Yuan asked him to put this drug on the market as soon as possible, Professor Ke Lun fully agreed, and he will do his best.

Professor Ke Lun didn't understand the principle of confidentiality at all. Professor Ke Lun thought that such a thing should be known to the public as soon as possible, but he didn't want to think whether it would cause delusions of unscrupulous people.No one doubted Professor Kelun's prestige, but the effect of the drug was still dubious. Under certain considerations, the clinical trials of the drug were carried out very quickly.

The clinical experiment does not depend on the source, many people with this disease are just waiting to die, so there may be a ray of life if they try it, no matter how bad the result is, they are dead. If you die in clinical practice, you can still provide for your family and friends. Relatives get some material compensation.

Under the attention of many caring people, the clinical trials are progressing steadily. Under the indulgence of Leandre, the news has also been inadvertently captured by the media, and a lot of attention has followed. However, there are many similar drugs in the world. I mentioned it, but most people only regard it as a new product. Before the effect comes out, no media dares to say for sure, and the public's discussion on it is only a topic. People who have cancer, and those who have relatives and friends who have cancer, all hold the expectation of success in their hearts.Everything has to be tested by time.

There is no need to hide it, Lyandel is also playing something big. After obtaining clinical approval, Nomus Group Pharmaceutical Company held a press conference.Nomus Group's brilliant achievements over the past year are not to be underestimated. The result of the group's rising influence is that all media have dispatched strong teams instead of just doing things half-heartedly.

In front of the flashing lights and gun barrels, the president of Nomus Group Pharmaceutical Company is not stage fright at all. As a group president, if he is stage frightened in such a scene, he can be laid off. "Thank you very much for coming to participate in the Nomus Group Pharmaceutical Company Press conference. It is a great honor to have the trust of Dr. Su, the chairman of the group company and the chief director of the pharmaceutical company's laboratory, to host this press conference."

"During this period of time, the anticancer drug that everyone has paid attention to was invented by Dr. Su, the chief experimental director of Nomus Group Company. Dr. Su's name has been widely recognized in the pharmacology circle in recent years. After graduation, Su Dr. Su has been devoting himself to the research of anti-cancer drugs. Finally, this spring, this drug has made a breakthrough. With the help of Dr. Su’s supervisor, Professor Ke Lun, this drug has gained a lot of attention, and it has also developed rapidly. The process has passed the clinical approval. Today's press conference is related to clinical trials." There is no need to add more notes about Su Yuan's affairs, many of them can be investigated.

"Cancer, for various reasons, has become a disease that endangers the health of hundreds of millions of human beings. How many patients are wailing under this incurable disease and can only wait for death to come, whether as a medical practitioner or as a Human beings are potentially threatened by cancer. I am looking forward to the birth of anti-cancer drugs. The former identity, this drug can bring us huge benefits, and the latter identity, this drug can save me from the disease. Harm." The president of the group company made a joke that caused the audience to laugh, which is true.Which pharmaceutical company does not want to have such a drug to gain fame and profit.

"Many people think that relying on modern technology, cancer is invincible, and they also maintain a skeptical attitude towards our company's anti-cancer drugs, thinking that this drug, like other anti-cancer products, only delays cancer and cannot Radical cure. Here, I can tell you, no, this drug invented by Dr. Su is to cure cancer and delay cancer, which is not what Dr. Su, nor our group company wants." The crowd announced.

The reporters at the venue began to discuss, is it really possible to cure cancer?The elite reporters who were able to be sent here have also had a preliminary understanding of the relevant content of the meeting. Many reporters from medical newspapers and magazines present have some attainments in this area. It is precisely because of their understanding that they have deep doubts .

"Please be quiet, everyone." The president of the pharmaceutical company had no choice but to make the scene quiet.The quality of the reporters nowadays is quite high, and they fell silent with just one sound, "Thank you very much. Our company is very confident about this drug, so we announced that we will disclose the whole process of clinical trials to the public."

Suddenly, a shocking news, the whole clinical process is made public. If it succeeds, there is nothing to say, but what if it fails?Once it fails, the Nomus Group pharmaceutical company will be ruined, and the Nomus Group will also be affected, not to mention the inventor, Dr. Su, in the industry, that Dr. Su will not be confused, in the hearts of the people , that Dr. Su is synonymous with failure, no matter what new inventions he has in the future, will anyone believe it?

"Okay, now, everyone can ask questions." The matter has been announced, and the president of the pharmaceutical company allowed the reporters to ask questions.The reporters raised their hands one after another, and the president of the pharmaceutical company clicked one.Of course, this is not a random point. Before pointing, the president has learned a little about the various media that came here, knowing which ones are sharp and which media are beneficial to him.

Under deliberate arrangements, the president kept the distribution of these media in mind.

"I want to ask, is your company so confident in this anticancer drug?" The reporter's question was still very gentle.

"As I have said, we are very confident in this drug. Our clinical trial will not fail." In fact, he had no idea at all. When he was notified, he opposed it, but the two directors insisted on going their own way. , he had no choice but to bite the bullet.The chance is half and half, he should believe that Nomus Group will create miracles, so many examples have appeared.He swears that if he really succeeds this time, he will not have any doubts about any incredible products and resolutions made by Nomus Group in the future, and he will fully support them.

After answering one question, the president of the pharmaceutical company clicked on the next one, "Dr. Su is indeed very famous in the field of pharmacology. The thesis that Dr. Su graduated last year caused quite a stir in the academic circle. However, Dr. Su has only 23 years old, at such an age, you can invent a cure for cancer, I would like to ask, is this done by Dr. Su independently, or under the guidance of his supervisor, Professor Ke Lun?” Accusing Su Yuan of stealing success, it is very difficult It's reserved, and this reporter is quite decent.

"There are many geniuses in this world. You know Dr. Su's achievements in academia, so you shouldn't doubt Dr. Su's talent. This drug to cure cancer was independently developed by Dr. Su. Professor Ke Lun's character and morality, in the There is no need for doubts in the academic world. If you have any doubts, you can also ask Professor Kelun in person. Please don’t make similar doubts again, otherwise we will take legal action.” The president replied to the reporter and also proposed warning. "Next person."

"I would like to ask, whether the media is allowed to conduct follow-up interviews in clinical trials?" The reporter's question is eye-catching.

"Of course, but the number of people is limited, we will choose the best." The president of the pharmaceutical company replied with a smile.The choice, of course, is in their hands. "Next person."

Questions were raised one after another, and the president of the Nomus Group pharmaceutical company also dealt with them easily, worthy of his annual salary of tens of millions.

"The clinical trial will be formally carried out in the morning of the day after tomorrow. In these two days, we will invite the media and invite authoritative cancer doctors to be in charge of the entire process, and will disclose various data at any time. The clinical trial period is one month, and patients will have A hundred patients with terminal cancers." This was the final release.